SWSarah Warner

Sarah Warner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Warner has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Sameer S. Kadri

    Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland

    4 shared publications
  • Christina Yek

    International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases

    3 shared publications
  • Alex Mancera

    Critical Care Medicine Department, National Institutes of Health Clinical Center, and National Heart, Lung, and Blood Institute, Bethesda, Maryland (M.N., S.W., A.M., J.S., C.Y., R.A., M.R., M.W., B.J.S., C.Y.D., S.S.K.)

    2 shared publications
  • Alexander Lawandi

    Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montréal, Québec , Canada

    2 shared publications
  • Cumhur Y. Demirkale

    Critical Care Medicine Department, National Institutes of Health Clinical Center, and National Heart, Lung, and Blood Institute, Bethesda, Maryland (M.N., S.W., A.M., J.S., C.Y., R.A., M.R., M.W., B.J.S., C.Y.D., S.S.K.)

    2 shared publications
  • Junfeng Sun

    Critical Care Medicine Department, National Institutes of Health Clinical Center, and National Heart, Lung, and Blood Institute, Bethesda, Maryland (M.N., S.W., A.M., J.S., C.Y., R.A., M.R., M.W., B.J.S., C.Y.D., S.S.K.)

    2 shared publications

Latest Publications

  • Association Between Hospital Type and Resilience During COVID-19 Caseload Stress

    by Maniraj Neupane, Sarah Warner, Alex Mancera, Junfeng Sun, Christina Yek, Sadia H. Sarzynski, Roxana Amirahmadi, Mary Richert, Emad Chishti, Morgan Walker, et al.

    Background: Imbalances between hospital caseload and care resources that strained U.S. hospitals during the pandemic have persisted after the pandemic amid ongoing staff shortages. Understanding which hospital types were more resilient to pandemic overcrowding-related excess deaths may prioritize patient safety during future crises. Objective: To determine whether hospital type classified by capabilities and resources (that is, extracorporeal membrane oxygenation [ECMO] capability, multiplicity of intensive care unit [ICU] types, and large or small hospital) influenced COVID-19 volume-outcome relationships during Delta wave surges. Design: Retrospective cohort study. Setting: 620 U.S. hospitals in the PINC AI Healthcare Database. Participants: Adult inpatients with COVID-19 admitted July to November 2021. Measurements: Hospital-months were ranked by previously validated surge index (severity-weighted COVID-19 inpatient caseload relative to hospital bed capacity) percentiles. Hierarchical models were used to evaluate the effect of log-transformed surge index on the marginally adjusted probability of in-hospital mortality or discharge to hospice. Effect modification was assessed for by 4 mutually exclusive hospital types. Results: Among 620 hospitals recording 223 380 inpatients with COVID-19 during the Delta wave, there were 208 ECMO-capable, 216 multi-ICU, 36 large (>= 200 beds) single-ICU, and 160 small (<200 beds) single-ICU hospitals. Overall, 50 752 (23%) patients required admission to the ICU, and 34 274 (15.3%) died. The marginally adjusted probability for mortality was 5.51% (95% CI, 4.53% to 6.50%) per unit increase in the log surge index (strain attributable mortality = 7375 [CI, 5936 to 8813] or 1 in 5 COVID-19 deaths). The test for interaction showed no difference (P = 0.32) in log surge index-mortality relationship across 4 hospital types. Results were consistent after excluding transferred patients, restricting to patients with acute respiratory failure and mechanical ventilation, and using alternative strain metrics. Limitation: Residual confounding. Conclusion: Comparably detrimental relationships between COVID-19 caseload and survival were seen across all hospital types, including highly advanced centers, and well beyond the pandemic's learning curve. These lessons from the pandemic heighten the need to minimize caseload surges and their effects across all hospital types during public health and staffing crises. Primary Funding Source: Intramural Research Program of the National Institutes of Health Clinical Center.


  • Open Access

    1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards

    by Jeffrey R Strich, Ahmed Ullah Mishuk, Alexander Lawandi, Guoqing Diao, Sarah Warner, Willy Li, Cumhur Y Demirkale, Alex Mancera, Morgan Walker, Christina Yek, et al.

    Sluggish uptake of novel gram-negative antibiotics has jeopardized their future development and supply potentially risking patient lives. Understanding underutilization patterns might better inform unmet needs and market entry rewards. We studied patterns and drivers of use of recently U.S. FDA-approved novel gram-negative agents in patients with gram-negative infections (GNI) displaying difficult-to-treat resistance (DTR; resistance to all first line B-lactams including carbapenems, and fluoroquinolones). Using the all-payer PINC-AI database, quarterly percent change in the post-approval use of seven gram-negative agents and secular trends in colistin use were calculated. For inpatients with DTR GNI at microbiology reporting hospitals, we compared novel vs older/reserve agent use by infection site and pathogen. At hospitals that use novel agents, generalized linear mixed models with weighting identified patient and hospital factors associated with the use of any novel (vs older/reserve) agents as targeted therapy against DTR GNI. Nearly half the patients in US hospital with DTR-GNIs are still receiving targeted therapy with older/reserve agents. While the value of novel agents is indicated by clinicians preferring them over older/reserve agents in sicker patients, future agents with distinctly novel mechanisms and activity against DTR-A. baumannii are needed to bridge the utilization gap. Morgan Walker, MD, Cytovale: Advisor/Consultant

  • Top Cited Papers
    Open Access

    Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020

    by Sameer S. Kadri, Junfeng Sun, Alexander Lawandi, Jeffrey R. Strich, Lindsay M. Busch, Michael Keller, Ahmed Babiker, Christina Yek, Seidu Malik, Janell Krack, et al.

    The effect of surges in COVID-19 caseload on COVID-19 survival rates is unclear, especially independent of temporal changes in survival. This retrospective cohort study used data from a large U.S. ... Visual Association Between Caseload Surge and COVID-19 Survival in U.S. Hospitals. The effect of surges in COVID-19 caseload on COVID-19 survival rates is unclear, especially independent o... Background: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival. Objective: T...